The information contained on the following web pages is intended exclusively for Swiss residents who are physically located in Switzerland. The following information does not contain or constitute an offer to sell or a solicitation of any offer to buy securities in the United States of America ("U.S.") or in any other jurisdiction in which such offer or solicitation is not authorized or to any person to whom it is unlawful to make an offer or solicitation. Users of this website are requested to inform themselves about and to observe any such restrictions. The securities of Sulzer AG’s (“Sulzer”) Applicator Systems division, or medmix (“medmix”), to be offered in connection with the planned capital increase referred to in the following web pages (the “Offering”) have not been and will not be registered under the United States securities laws and may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. Neither medmix nor Sulzer intends to register any portion of the Offering in the United States or conduct a public offering of securities in the United States. The information contained on the following web pages may not be distributed outside of Switzerland, in particular not in the U.S.
This communication is only being distributed to and is only directed at persons who are out-side the United Kingdom ("U.K.") (all such persons together being referred to as "relevant persons"). Any person who is not a relevant person should not act or rely on the following web pages or any of their contents. The securities subject to the Offering are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons and certain other persons to whom it may lawfully be communicated.
Some of the information published on this website contains forward-looking statements. Users are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. medmix and Sulzer undertake no obligation to publicly update or revise any information or opinions published on the website and reserve the right to amend the information at any time without prior notice.
The information contained on this website may not be considered as being a substitute for economic, legal, tax or other advice, and users are cautioned not to base investment decisions or other decisions solely on the content of this website. An investment decision with respect to the Offering must only be made on the basis of a prospectus to be published in accordance with Swiss law. Users must consult their investment advisers or other advisers prior to making any investment decisions.